STAAR Surgical Co Increase (Decrease) in Other Operating Liabilities
STAAR Surgical Co (STAA) reported Increase (Decrease) in Other Operating Liabilities of -$4.56 million for the 12-month period ending 2026-01-02, per its 10-K filed 2026-03-03.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingLiabilities · last filed 2026-05-13
- STAAR Surgical Co increase (decrease) in other operating liabilities for the quarter ending 2026-01-02 was $629.00K, a 81.86% decline year-over-year.
- STAAR Surgical Co increase (decrease) in other operating liabilities for the quarter ending 2025-09-26 was $2.24M, a 18.40% decline year-over-year.
- STAAR Surgical Co increase (decrease) in other operating liabilities for the quarter ending 2025-06-27 was -$11.71M.
- STAAR Surgical Co increase (decrease) in other operating liabilities for the quarter ending 2025-03-28 was $4.28M.
- STAAR Surgical Co increase (decrease) in other operating liabilities for fiscal 2026 was -$4.56M.
- STAAR Surgical Co increase (decrease) in other operating liabilities for fiscal 2024 was -$169.00K, a 102.37% decline from fiscal 2023.
- STAAR Surgical Co increase (decrease) in other operating liabilities for fiscal 2023 was $7.14M.
| Period end | Increase (Decrease) in Other Operating Liabilities 3 month | Increase (Decrease) in Other Operating Liabilities 6 month | Increase (Decrease) in Other Operating Liabilities 9 month | Increase (Decrease) in Other Operating Liabilities 12 month |
|---|---|---|---|---|
| 2026-01-02 | $629.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $2.87M derived: sum of 2 quarters · filed 2026-03-03 | -$8.84M derived: sum of 3 quarters · filed 2026-03-03 | -$4.56M 10-K · filed 2026-03-03 |
| 2025-09-26 | $2.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$9.46M derived: sum of 2 quarters · filed 2025-11-05 | -$5.19M 10-Q · filed 2025-11-05 | -$1.72M derived: sum of 4 quarters · filed 2026-05-13 |
| 2025-06-27 | -$11.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$7.43M 10-Q · filed 2025-08-06 | -$3.96M derived: sum of 3 quarters · filed 2026-05-13 | -$1.21M derived: sum of 4 quarters · filed 2026-05-13 |
| 2025-03-28 | $4.28M 10-Q · filed 2026-05-13 | $7.75M derived: sum of 2 quarters · filed 2026-05-13 | $10.50M derived: sum of 3 quarters · filed 2026-05-13 | |
| 2024-12-27 | $3.47M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $6.22M derived: sum of 2 quarters · filed 2026-03-03 | -$169.00K 10-K · filed 2026-03-03 | |
| 2024-09-27 | $2.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$3.64M 10-Q · filed 2025-11-05 | ||
| 2024-06-28 | -$6.39M 10-Q · filed 2025-08-06 | |||
| 2023-12-29 | $7.14M 10-K · filed 2026-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| RxSight, Inc. (RXST) | United States | $0.197B | |
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |